Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wesche

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
JAMA Network Open|January 16, 2019
Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax MalariaJ Kevin Baird, Melva Louisa, Rintis Noviyanti, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 30, 2020
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cureSelvi Srinivasan, Debashish Roy, Thomas E J Chavas, et al.
Science Advances|April 19, 2024
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cureAyumi E Pottenger, Debashish Roy, Selvi Srinivasan, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
JAMA Network Open|January 16, 2019
Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax MalariaJ Kevin Baird, Melva Louisa, Rintis Noviyanti, et al.
CPT: Pharmacometrics & Systems Pharmacology|August 17, 2023
Development and application of a PBPK modeling strategy to support antimalarial drug developmentNada Abla, Eleanor Howgate, Karen Rowland-Yeo, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 30, 2020
Liver-targeted polymeric prodrugs of 8-aminoquinolines for malaria radical cureSelvi Srinivasan, Debashish Roy, Thomas E J Chavas, et al.
Science Advances|April 19, 2024
Liver-targeted polymeric prodrugs delivered subcutaneously improve tafenoquine therapeutic window for malaria radical cureAyumi E Pottenger, Debashish Roy, Selvi Srinivasan, et al.
Plos Medicine|March 6, 2020
Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient dataXin Hui S Chan, Yan Naung Win, Ilsa L Haeusler, et al.
Pageof 3